MIGUEL ÁNGEL
TEJADA GIRÁLDEZ
PROGRAMA JUAN DE LA CIERVA
Johns Hopkins University School of Medicine
Baltimore, Estados UnidosPublicaciones en colaboración con investigadores/as de Johns Hopkins University School of Medicine (1)
2022
-
Phenotypic drug screen uncovers the metabolic GCH1/BH4 pathway as key regulator of EGFR/KRAS-mediated neuropathic pain and lung cancer
Science Translational Medicine, Vol. 14, Núm. 660